Final Program in it's entirety - MyGirlsBlood

Recommendations

Info

Posters, Tuesday and Wednesday Index of Poster Presenters cont’d VENOUS ACCESS 34P04 Outcomes of Portacaths in Children with Hemophilia: A Comprehensive Care Centre Approach Efford J, Baker K, Henderson L, Liesner R, Khair K, Mathias M Great Ormond Street Hospital Haemophilia Comprehensive Care Centre, London, U.K. 34P05 Peripheral Arteriovenous Shunts for Venous Access in Children with Hemophilia Male C1 , Thom K1 , Hölzenbein T2 , Zwiauer K3 , Endres G4 1Department of Paediatrics, Medical University of Vienna, Austria, 2Department of Vascular Surgery, Landeskrankenhaus Salzburg, Austria, 3Department of Pediatrics, Landesklinikum St. Pölten, Austria, 4Department of Pediatrics, Landeskran - kenhaus Bregenz, Austria 34P06 Incidence of Sports in Patients with Hemophilia A and Inhibitor Torres Ortuño AI, Cuesta Barriuso R y Moreno MM Asociación Regional Murciana De Hemofilia, Murcia, Spain 34P07 Relationship between the Management of Port-A-Cath in Children and Degree of Parental Stress Torres Ortuño AI, Cuesta Barriuso R y Moreno MM Asociación Regional Murciana De Hemofilia, Murcia, Spain 34P08 Capturing Daily Home Treatment and Quality of Life Assessments in Congenital Hemophilia with Inhibitors (CHwI): Design, Disposition and Implications of the Dosing Observational Study in Hemophilia (DOSE) G. Young1 , D.L. Cooper2 , K. Hoffman3 , J. Kabawat3 and C.T. Wilke4 . 1Childrens Hospital of Los Angeles, Los Angeles, California U.S.A., 2Novo Nordisk Inc., Princeton, New Jersey U.S.A., 3Outcome Sciences, Inc., Cambridge, Massachusetts U.S.A., 4University of Illinois, Chicago, Chicago, Illinois U.S.A. 34P09 Improved Chance of Success? Hand Exercise and IV Access Hollingdrake O, Stewart M, Zeissink B Queensland Haemophilia Centre, Queensland, Australia 34P10 Teaching Intravenous Access: A Survey of Practice Patterns in Australia Zeissink B Australian Haemophilia Nurse’s Group, Queensland, Australia 88 VON WILLEBRAND DISEASE 35P02 A New Immunoturbidimetric Mono-Reagent Kit for VWF:Ag in Q Hemostasis Analyzer Ambros R 1 , Gassó S 2 , Montanini V 1 , Berga V 2 , Civit G 1 1 Diagnostic Grifols and 2 Spinreact, Barcelona, Spain 35P03 Presence of a Common Haplotype in the Turkish VWD Patients Berber E 1 , Dagdemir A 2 , Pehlevan F 2 , Akin M 1 , Kavakli K 1 , Caglayan S 3 1 Ege University, 2 Halic University, and 3 Bogazici University, Istanbul, Turkey 35P04 Von Willebrand Disease Prophylaxis Network Abshire T1 , Bowen J2 , Berntorp E3 1 2 BloodCenter of Wisconsin, Milwaukee, WI, U.S.A., Rho, Inc., Chapel Hill, NC, U.S.A., 3Centre for Thrombosis and Haemostasis, Malmö University Hospital, Lund University, Malmö, Sweden 35P05 Prospective Validation of a Modified von Willebrand Score in Children Bidlingmaier C1 , Olivieri M1 , Budde U2 , Kurnik K1 1Children’s University Hospital Munich, Germany, 2Coagulation Laboratory Hamburg, Germany 35P06 Focus On Gynecological & Obstetrics Procedures In Women with von Willebrand Disease (VWD): Data From A French Clinical Postmarketing Survey Of A High-Purity von Willebrand Factor Concentrate with a Low Factor VIII Content Borel-Derlon A1 , Goudemand J2 , Boyer-Neumann C3 , Sié P4 , Bertrand M5 , Post Marketing Study Group6 , Henriet C7 , Bridey F7 , Chatelanaz C7 1Haemophilia Centre, University Hospital Centre, Caen, 2Haemophilia Centre, University Hospital Centre, Lille, 3Haematology Laboratory, A-Béclère Hospital, Clamart, 4Haemophilia Centre, University Hospital Centre, Toulouse, 5Haemophilia Centre, University Hospital Centre, Besançon, 6 7 French HTC, LFB, LES ULIS, France
Index of Poster Presenters cont’d 35P07 Type 2N (Normandy) von Willebrand Disease (VWD) – A Report of 3 Cases Misdiagnosed as Hemophilia A Carcao M1 , Stain A2 , Lillicrap D3 , Leggo J3 , Blanchette V1 1 2 Division of Haematology/Oncology and Dept. of Nursing, Hospital For Sick Children, Toronto, ON, Canada, 3Dept. of Pathology and Molecular Medicine, Queen’s University, Kingston, ON, Canada 35P08 Correlation of Three Functional Assays for von Willebrand Factor Activity Determination Chen Y1,2 , Tsai W1,2 , Hu S1 , Cheng S1,3 , Chao T1,2 1 2 Hemophilia Care & Research Center, Division Hematology/Oncology, Department of Internal Medicine, 3Department of Pediatric, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan 35P09 Impact of von Willebrand Disease on Health Related Quality of Life in a Pediatric Population De Wee E1 , Fijnvandraat K2 , De Goede-Bolder A3 , Mauser- Bunschoten E4 , Van der Bom J5 , Leebeek F1 1Hematology, Erasmus University Medical Center Rotterdam, the Netherlands, 2Pediatric Hematology, Emma Children’s Hospital AMC, Amsterdam, the Netherlands, 3Pediatrics, Erasmus MC, Sophia Children’s Hospital, Rotterdam, the Netherlands, 4Van Creveldkliniek and Hematology, University Medical Center Utrecht, the Netherlands, 5Department of Clinical Epidemiology, Leiden University Medical Center, the Netherlands 35P10 Acquired von Willebrand Syndrome in Monoclonal Gammopathies Djunic I1 , Elezovic I1 , Tomin D1 , Antic D1 , Ilic V2 , Milosevic- Jovcic N2 1Institute of Haematology, Clinical Center Of Serbia, Belgrade, Serbia, 2Institute for Medical Research, Belgrade, Serbia 35P11 Clinical Use of Haemate-P in Inherited von Willebrand Disease: A Patient with Type 3 VWD and Recurrent Menometrorrhagia Dolatkhah R, Asvadi Kermani I, Sanaat Z, Seifi S Heamtology and Oncology Research Centre, Tabriz University of Medical Sciences, Shahid Ghazi Hospital, Tabriz, Iran 35P12 Chronic Oral Anticoagulation in Patients with Inherited Bleeding Disorders Cruz E, Morais S, Campos M, Pinho N, Moreira L, Miranda M Hematology Unit, Santo António Hospital, Porto, Portugal 35P13 Pregnancy in Type 3 von Willebrand Disease Morais S, Cruz E, Pereira M, Campos M Hematology Unit, Santo António Hospital, Porto, Portugal 35P14 Frequency of Discrepant VWF:RCo/VWF:Ag Ratios and Thrombocytopenia in a Cohort of Children with Type 2b von Willebrand Disease Frontroth J, Hepner M, Pieroni G, Annetta E, Castañón M, Bonduel M Hospital De Pediatria Prof Dr Juan P Garrahan, Buenos Aires, Argentina 35P15 Methodology of Ristocetin-Induced Platelet-Aggregation (Ripa) Mixing Studies in Type 2b von Willebrand Disease Frontroth J, Hepner M, Pieroni G, Annetta E, Castañón M, Bonduel M Hospital De Pediatria Prof Dr Juan P Garrahan, Buenos Aires, Argentina 35P16 Use of Haemoctin for Bleeding Episodes in Type 3 von Willebrand Disease Gouider E, Zahra K, Zorgan M, Balkis M Hemophilia Treatment Centre Aziza Othmana Hospital, Tunis, Tunisia 35P17 Long-term Prophylactic Treatment of Juvenile von Willebrand Type 2 and 3 Patients with Two Different von Willebrand Factor Concentrates – a Two-Center Cohort Study Halimeh S1 , Krümpel A2 , Rott H1 , Manner D2 , Mesters R3 , Nowak-Göttl U2 1 2 MVZ Laboratory Duisburg GmbH, Germany, University Hospital Muenster, Germany Dep. of Pediatrics, 3University Hospital Muenster, Germany 35P18 Treatment of a Patient with Type 3 von Willebrand Disease and Alloantibody against von Willebrand Factor Halimeh S1 , Faeser B1 , Budde U2 , Laws H3 , Rott H1 1MVZ Laboratory Duisburg GmbH, Germany, 2 3 AescuLaboratory Hamburg, Germany, University Hospital Duesseldorf, Germany 89 Posters, Tuesday and Wednesday
Page 1 and 2:
Hemophilia Saturday, July 10 - Wedn
Page 3 and 4:
Pre-Congress Sessions cont’d 10:3
Page 5 and 6:
Pre-Congress Sessions cont’d 15:0
Page 7 and 8:
Congress Sessions cont’d S1.6 - M
Page 9 and 10:
Congress Sessions cont’d S2.5 - M
Page 11 and 12:
Congress Sessions cont’d n Long T
Page 13 and 14:
Congress Sessions cont’d M2.4 - M
Page 15 and 16:
Congress Sessions cont’d Tuesday,
Page 17 and 18:
Congress Sessions cont’d 14:15 -
Page 19 and 20:
Congress Sessions cont’d T3.4 - M
Page 21 and 22:
Congress Sessions cont’d n Inhibi
Page 23 and 24: Congress Sessions cont’d W2.4 - L
Page 25 and 26: Index of Speakers cont’d Halimeh,
Page 27 and 28: Index of Poster Presenters Sunday a
Page 29 and 30: Index of Poster Presenters cont’d
Page 73: Index of Poster Presenters cont’d
show all

Final Program in it's entirety - MyGirlsBlood

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?